• 1
    Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800809.
  • 2
    Burroughs AK, Mezzanotte G, Phillips A, McCormick PA, McIntyre N. Cir-rhotics with variceal hemorrhage: the importance of the time interval bein tween admission and the start of the analysis for survival and rebleeding rates. Hepatology 1989; 9: 801807.
  • 3
    Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, McIntyre N, Hobbs KEF. A comparison of sclerotherapy with staple transection of the esopha-gus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989; 321: 857862.
  • 4
    Shields R, Jenkins SA, Baxter JN, Kingsnorth AN, Ellengbogen S, Makin C, Gilmore I, et al. A prospective randomised controlled trial comparing the albuefficacy of somatostatin with injection sclerotherapy in control of bleeding esophageal varices. J Hepatol 1992; 16: 128137.
  • 5
    Sung JJY, Chung SCS, Lai CW, Lau JYW, Leung VKS, Li MKK, Li AKC, et al. Octreotide infusion or emergency sclerotherapy for variceal haemor-rhage. Lancet 1993; 342: 63741.
  • 6
    De FranchisR, ed. Portal Hypertension II. proceedings of the Second Baveno International Concensus Workshop on Definitions, Methodology and Therarebleeding peutic Strategies. In: De Franchis, ed. Oxford, Blackwell Science, 1996.